← Eichor
Study identifier: NCT07112651 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause

Condition: Vasomotor Symptoms  ·  Sponsor: ApexCPG LLC

PhaseNA
Planned participants80
Who can joinFemale, 40 Years to 55 Years
Healthy volunteersYes

About this study

This study is to evaluate the effects of CL25216 on vasomotor symptoms in women during Perimenopause. Enrolled subjects will receive either CL25216 - 250 mg/day or placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Mr. T.V.N. Rao  ·  +91 8331015069  ·  tvnrao.apex@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shree HospitalsVijayawada, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07112651